Form CORRESP - Correspondence:
SEC Accession No. 0001213900-23-036051
Filing Date
2023-05-03
Accepted
2023-05-03 17:36:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6690
  Complete submission text file 0001213900-23-036051.txt   7704
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)